Financial Counselors Inc’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,815
Closed -$3.89M 600
2024
Q2
$3.89M Buy
11,815
+374
+3% +$132K 0.06% 205
2024
Q1
$4.53M Buy
11,441
+125
+1% +$46.2K 0.08% 198
2023
Q4
$3.98M Sell
11,316
-71
-0.6% -$25.1K 0.07% 204
2023
Q3
$4.27M Buy
11,387
+1,893
+20% +$732K 0.09% 187
2023
Q2
$3.63M Buy
9,494
+117
+1% +$41.8K 0.07% 198
2023
Q1
$3.25M Buy
+9,377
New +$2.74M 0.07% 207
2018
Q2
Sell
-9,386
Closed -$829K 512
2018
Q1
$829K Sell
9,386
-153
-2% -$14.3K 0.04% 292
2017
Q4
$941K Buy
9,539
+377
+4% +$37K 0.04% 282
2017
Q3
$882K Sell
9,162
-5,832
-39% -$528K 0.04% 287
2017
Q2
$1.42M Buy
14,994
+577
+4% +$53.1K 0.07% 250
2017
Q1
$1.18M Sell
14,417
-421
-3% -$35.2K 0.06% 265
2016
Q4
$1.26M Buy
+14,838
New +$1.17M 0.07% 251
2016
Q2
$824K Buy
10,865
+2,167
+25% +$158K 0.05% 273
2016
Q1
$603K Buy
+8,698
New +$523K 0.04% 296

Other funds holding WST

Financial Counselors Inc's WST Position: Q3 2024 in Review

Financial Counselors Inc sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 11,815 shares — an estimated $3.89M sold.

Financial Counselors Inc first reported a position in WST in Q1 2016 and held it in 14 quarters. The position peaked at $4.53M in Q1 2024. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • Financial Counselors Inc reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • Financial Counselors Inc sold 11,815 West Pharmaceutical shares in Q3 2024, an estimated $3.89M.
  • Financial Counselors Inc first reported a position in West Pharmaceutical in Q1 2016 and held it in 14 quarters.
  • Financial Counselors Inc's West Pharmaceutical position peaked at $4.53M in Q1 2024.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on Financial Counselors Inc's 13F filing for Q3 2024, filed 14 Nov 2024.